These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 1698935)
1. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance. Hansen SW; Berthelsen JG; von der Maase H J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935 [TBL] [Abstract][Full Text] [Related]
2. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer. Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096 [TBL] [Abstract][Full Text] [Related]
3. Testicular function in patients with testicular cancer treated with orchiectomy alone or orchiectomy plus cisplatin-based chemotherapy. Hansen PV; Trykker H; Helkjoer PE; Andersen J J Natl Cancer Inst; 1989 Aug; 81(16):1246-50. PubMed ID: 2474077 [TBL] [Abstract][Full Text] [Related]
4. Gonadal function after multimodality treatment in men with testicular germ cell cancer. Palmieri G; Lotrecchiano G; Ricci G; Spiezia R; Lombardi G; Bianco AR; Torino G Eur J Endocrinol; 1996 Apr; 134(4):431-6. PubMed ID: 8640293 [TBL] [Abstract][Full Text] [Related]
5. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy. Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T J Androl; 2009; 30(3):280-6. PubMed ID: 19136393 [TBL] [Abstract][Full Text] [Related]
6. Reproductive toxicity with and without LHRHA administration during adjuvant chemotherapy in patients with germ cell tumors. Kreuser ED; Hetzel WD; Hautmann R; Pfeiffer EF Horm Metab Res; 1990 Sep; 22(9):494-8. PubMed ID: 1701752 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin. Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832 [TBL] [Abstract][Full Text] [Related]
8. Fertility after chemotherapy for testicular cancer. Drasga RE; Einhorn LH; Williams SD; Patel DN; Stevens EE J Clin Oncol; 1983 Mar; 1(3):179-83. PubMed ID: 6199473 [TBL] [Abstract][Full Text] [Related]
9. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288 [TBL] [Abstract][Full Text] [Related]
10. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800 [TBL] [Abstract][Full Text] [Related]
11. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M; J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040 [TBL] [Abstract][Full Text] [Related]
12. The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors. Gerl A; Mühlbayer D; Hansmann G; Mraz W; Hiddemann W Cancer; 2001 Apr; 91(7):1297-303. PubMed ID: 11283930 [TBL] [Abstract][Full Text] [Related]
13. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors. Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937 [TBL] [Abstract][Full Text] [Related]
14. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis. Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213 [TBL] [Abstract][Full Text] [Related]
15. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858 [TBL] [Abstract][Full Text] [Related]
16. The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer. Petersen PM; Hansen SW Ann Oncol; 1999 Dec; 10(12):1475-83. PubMed ID: 10643539 [TBL] [Abstract][Full Text] [Related]
17. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O; Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037 [TBL] [Abstract][Full Text] [Related]
18. Experience with PVB in non seminomatous germ-cell cancer of the testis. Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336 [No Abstract] [Full Text] [Related]
19. Pituitary and testicular hormonal function after treatment for germ cell tumours. Bosl GJ; Bajorunas D Int J Androl; 1987 Feb; 10(1):381-4. PubMed ID: 2438229 [TBL] [Abstract][Full Text] [Related]
20. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution. Germá JR; Sagarra AF; Izquierdo MA; Seguí MA Cancer; 1993 Feb; 71(3):796-803. PubMed ID: 7679314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]